article thumbnail

Nasal spray safely treats recurrent abnormal heart rhythms, clinical trial suggests

Science Daily - Heart Disease

A clinical trial showed that a nasal spray that patients administer at home, without a physician, successfully and safely treated recurrent episodes of a condition that causes rapid abnormal heart rhythms.

article thumbnail

CardioFocus to Present Data Supporting Next Generation Pulsed Field Ablation Systems at Heart Rhythm 2024

DAIC

a medical device company dedicated to advancing ablation treatment for cardiac arrythmias, announced its participation at the Heart Rhythm 2024 conference, taking place in person at the Boston Convention & Exhibition Center and virtually, May 16-19, 2024. EDT, in Rhythm Theater #2. Data Driven Pulsed Field Abstracts Shephal K.

article thumbnail

Wearable heart monitor increases diagnosis of irregular heart rhythm

Science Daily - Stroke

Wearable, long-term continuous heart monitors helped identify 52% more cases of atrial fibrillation compared to usual care, but that did not lead to a reduction in hospitalizations due to stroke, according to a new study.

article thumbnail

Increased Risk of Heart Rhythm Disruption After COVID-19

DAIC

Ioannis Katsoularis, image courtesy of Klas Sjöberg milla1cf Thu, 12/14/2023 - 09:23 December 14, 2023 — Individuals infected with COVID-19 are also at an increased risk of suffering from heart rhythm disturbances, such as atrial fibrillation.

COVID-19 111
article thumbnail

Innovative Health Reports Strong Growth in Cost and Environmental Savings for EP Labs at the 2024 Heart Rhythm Society Conference

DAIC

These reductions in cost and carbon emissions will help shape conversations around the value of medical technology re-use at the annual Heart Rhythm Society conference in Boston. I am hopeful that Heart Rhythm Society’s conference will reflect this.” electrophysiology labs.

article thumbnail

First Heart Rhythm Patients in Southern Italy Treated with Advanced Robotic Technology

DAIC

milla1cf Tue, 06/11/2024 - 18:09 June 11, 2024 — Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced that Hospital Santa Maria della Pietà, in Nola in the Metropolitan City of Naples, has established the first robotic cardiac heart program in Southern Italy.

article thumbnail

Late-breaking Clinical Trial Results from FARADISE, adMIRE Study and Advent Trial at Heart Rhythm 2024 Highlight Pulsed Field Ablation Developments for Atrial Fibrillation Treatment

DAIC

During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF). director of electrophysiology, Mount Sinai Fuster Heart Hospital , New York.